Alpha-adrenoceptor subtypes and regional myocardial blood flow distribution during coronary occlusion in dogs

Fundam Clin Pharmacol. 1991;5(2):117-28. doi: 10.1111/j.1472-8206.1991.tb00705.x.

Abstract

The involvement of postsynaptic alpha-adrenoceptors in the distribution of regional myocardial blood flows (RMBFs, microsphere technique) within the left ventricle has been investigated during intermittent coronary artery occlusion in open-chest anesthetized dogs. Two types of RMBFs distribution were assessed: (1) between endocardial (endo) and epicardial (epi) layers (endo/epi ratio) and (2) between nonischemic (NIZ) and ischemic zones (IZ) (IZ/NIZ ratio). Equipressor does of selective alpha 1-(cirazoline after rauwolscine) and alpha 2-(UK-14,304 after prazosin) adrenoceptor agonists were infused in dogs previously submitted to ganglionic and muscarinic blockade. In a control group, aortic pressure was mechanically raised by aortic stenosis to levels similar to those reached with both alpha-adrenoceptor agonists. Cirazoline and aortic stenosis increased RMBFs in IZ and NIZ but did not alter the calculated coronary resistance in NIZ and did not affect endo/epi and IZ/NIZ ratios. In contrast, UK-14,304 preferentially augmented coronary resistance in NIZ, increased IZ/NIZ ratio (both P less than 0.05) but did not affect endo/epi ratio in IZ and NIZ. Thus, we conclude that if transmural distribution of RMBFs (endo/epi ratio) is not preferentially controlled by any alpha-adrenoceptor subtype, postsynaptic alpha 2-adrenoceptors are of importance during coronary occlusion in promoting a favorable redistribution of RMBFs from NIZ towards IZ by inducing a selective NIZ coronary vasoconstriction (ie a "reverse coronary steal").

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Blood Pressure / drug effects
  • Brimonidine Tartrate
  • Coronary Circulation / physiology*
  • Coronary Vessels / physiology*
  • Dogs
  • Female
  • Imidazoles / pharmacology
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Quinoxalines / pharmacology
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / metabolism*
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Imidazoles
  • Quinoxalines
  • Receptors, Adrenergic, alpha
  • Yohimbine
  • Brimonidine Tartrate
  • cirazoline